1. Home
  2. ONMD vs PRPO Comparison

ONMD vs PRPO Comparison

Compare ONMD & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

N/A

Current Price

$0.59

Market Cap

42.1M

Sector

N/A

ML Signal

N/A

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$29.70

Market Cap

42.0M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ONMD
PRPO
Founded
2006
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
42.1M
42.0M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
ONMD
PRPO
Price
$0.59
$29.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
810.4K
104.8K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
83.33
92.15
EPS
N/A
N/A
Revenue
$1,359,000.00
$24,049,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
111.35
29.77
52 Week Low
$0.49
$14.04
52 Week High
$4.22
$33.63

Technical Indicators

Market Signals
Indicator
ONMD
PRPO
Relative Strength Index (RSI) 43.19 75.23
Support Level $0.58 $22.25
Resistance Level $0.83 $33.63
Average True Range (ATR) 0.07 1.92
MACD -0.01 0.82
Stochastic Oscillator 16.98 100.00

Price Performance

Historical Comparison
ONMD
PRPO

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About PRPO Precipio Inc.

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Share on Social Networks: